ICCC vs PETZ

For growth investors, TDH Holdings, Inc.

(PETZ) is the stronger pick with 122. 0% revenue growth year-over-year, versus 51. 6% for ImmuCell Corporation (ICCC). TDH Holdings, Inc. (PETZ) offers the better valuation at 5. 7x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, ImmuCell Corporation (ICCC) delivered a total return of -15.

3%, compared to -97. 7% for TDH Holdings, Inc. (PETZ). Over 10 years, the gap is even starker: ICCC returned +22. 2% versus PETZ's -99. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TDH Holdings, Inc.

(PETZ) is the lower-risk stock at 0. 26β versus ImmuCell Corporation's 0. 42β — meaning ICCC is approximately 63% more volatile than PETZ relative to the S&P 500. On balance sheet safety, TDH Holdings, Inc. (PETZ) carries a lower debt/equity ratio of 13% versus 55% for ImmuCell Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), TDH Holdings, Inc.

(PETZ) is pulling ahead at 122. 0% versus 51. 6% for ImmuCell Corporation (ICCC). On earnings-per-share growth, the picture is similar: ImmuCell Corporation grew EPS 65. 3% year-over-year, compared to -15. 0% for TDH Holdings, Inc.. Over a 3-year CAGR, ICCC leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

TDH Holdings, Inc.

(PETZ) is the more profitable company, earning 143. 8% net margin versus -8. 1% for ImmuCell Corporation — meaning it keeps 143. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICCC leads at -6. 2% versus -146. 3% for PETZ. At the gross margin level — before operating expenses — ICCC leads at 30. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, TDH Holdings, Inc.

(PETZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 26)). Both have compounded well over 10 years (PETZ: -99. 2%, ICCC: +22. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ICCC (Healthcare) and PETZ (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.